4/22
04:18 pm
lyel
Form ARS Lyell Immunopharma, Inc. For: Dec 31
Low
Report
Form ARS Lyell Immunopharma, Inc. For: Dec 31
4/22
04:17 pm
lyel
Form DEFA14A Lyell Immunopharma, Inc.
Low
Report
Form DEFA14A Lyell Immunopharma, Inc.
4/22
04:16 pm
lyel
Form DEF 14A Lyell Immunopharma, Inc. For: Jun 14
Low
Report
Form DEF 14A Lyell Immunopharma, Inc. For: Jun 14
2/29
06:21 am
lyel
Form S-3 Lyell Immunopharma, Inc.
Low
Report
Form S-3 Lyell Immunopharma, Inc.
2/29
06:18 am
lyel
Form S-8 Lyell Immunopharma, Inc.
Low
Report
Form S-8 Lyell Immunopharma, Inc.
2/28
05:33 pm
lyel
Form 10-K Lyell Immunopharma, Inc. For: Dec 31
Low
Report
Form 10-K Lyell Immunopharma, Inc. For: Dec 31
2/28
04:11 pm
lyel
Form 8-K Lyell Immunopharma, Inc. For: Feb 28
Medium
Report
Form 8-K Lyell Immunopharma, Inc. For: Feb 28
2/14
03:19 pm
lyel
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: ARCH Venture Fund IX, L.P.
Neutral
Report
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: ARCH Venture Fund IX, L.P.
2/13
08:26 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lang Matthew
Medium
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lang Matthew
2/13
08:24 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Hill Stephen J.
Medium
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Hill Stephen J.
2/13
08:22 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lee Gary K.
Medium
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lee Gary K.
2/13
08:19 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Newton Charles W.
Medium
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Newton Charles W.
2/13
08:18 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Seely Lynn
Medium
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Seely Lynn
2/13
05:14 pm
lyel
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: VANGUARD GROUP INC
1/29
05:27 pm
lyel
Form SC 13G Lyell Immunopharma, Inc. Filed by: BlackRock Inc.
Medium
Report
Form SC 13G Lyell Immunopharma, Inc. Filed by: BlackRock Inc.